Detailed price information for Nautilus Biotechnology Inc (NAUT-Q) from The Globe and Mail including charting and trades.

The global chromatography instruments market is set to witness a growth rate of 5% in the next 5 years. Growing application in pharmaceutical and biotech R&D; growing food safety concerns, ...

Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that the company will be participating in the upcoming Canaccord Genuity 45th Annual ...

Beyond healthcare OneMedNet's proprietary AI anonymizes data for industries like finance, retail, and telecom, unlocking endless possibilities, rigorously testing production system upgrades, ...

Researchers at the UConn Center on Aging have uncovered causal links between depression and Alzheimer’s disease and related ...

Bone and joint diseases pose a significant global health challenge, adversely impacting millions of individuals and exerting substantial socioeconomic ...

Nautilus will host a conference call to discuss the second quarter 2025 financial results, business developments and outlook before market open on Thursday, July 31, 2025, at 5:30 AM Pacific Time / ...

Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or "Nautilus"), a company pioneering a single-molecule proteome analysis platform, today reported financial results ...

From overlooked diagnostics and underused screening to AI potential and workforce gaps, these are the innovation challenges in oncology that cancer leaders told Becker’s they feel deserve more ...

LCGC International spoke to Evelyn Rampler of the Department of Analytical Chemistry at the University of Vienna about the ...

Reduce development timelines and costs, while improving access to life-saving treatments VANCOUVER, BC / ACCESS Newswire / July 30, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfur ...

Advances in artificial intelligence (AI) are revolutionizing the way we observe, quantify, and interpret the microscopic ...